News about Market

ABS Bio Buys Cureline, Enhancing Biospecimen Access and Execution

The add-on acquisition of Cureline by ABS Bio, a 3 Boomerang portfolio company, expands ABS Bio’s capabilities, geographic reach and client base while strengthening its end-to-end biospecimen services.

Market | 08/01/2026 | By News Bureau |  148

Dr Reddy's Launches Recombinant Hepatitis E Vaccine Hevaxin in India

According to Dr Reddy’s, clinical studies show that Hevaxin offers protective efficacy, durable immunity, and a favourable immune response, supported by an established safety and tolerability profile.

Market | 07/01/2026 | By News Bureau |  172

Esco Aster Signs cGMP Exosome Manufacturing Deal with Shine-On Biomedical

Esco Aster has entered into a clinical cGMP manufacturing agreement with Shine-On Biomedical to support the production of a first-in-class HLA-G–targeting exosome drug delivery platform, while also providing technical services for exploratory exosome loading feasibility studies to advance the programme’s development.

Market | 07/01/2026 | By News Bureau |  129

Novo Nordisk Introduces Wegovy Pill with knownwell as NovoCare Provider

Novo Nordisk has launched Wegovy in an oral pill form, marking the first FDA-approved oral GLP-1 therapy, with knownwell recognised as a NovoCare provider to support broader patient access to clinician-led metabolic care across the US.

Market | 06/01/2026 | By News Bureau |  144

Generic Drug Maker Hindustan Laboratories Files IPO Papers With SEBI

Hindustan Laboratories, an Indian manufacturer of generic pharmaceutical formulations, has filed draft papers with the Securities and Exchange Board of India (SEBI) to launch an initial public offering (IPO).

Market | 06/01/2026 | By Darshana |  128

Torrent Pharma Approves USD 1.51 Billion Bond Fundraising Plan

Torrent Pharmaceuticals has approved a plan to raise up to USD 1.51 billion through the issuance of secured, rated, listed and redeemable non-convertible debentures (NCDs), according to a regulatory filing.

Market | 06/01/2026 | By Darshana |  195

Samsung Bioepis Launches BYOOVIZ Biosimilar in Europe

Samsung Bioepis has completed the transfer of BYOOVIZ commercial rights from Biogen, making it the company’s fourth biosimilar directly marketed in Europe, with a pre-filled syringe launch planned for Q2 2026.

Market | 03/01/2026 | By News Bureau |  154

Intelligent Bio Solutions Forms New Manufacturing Partnership to Boost Global Production and Margins

Intelligent Bio Solutions has entered into a manufacturing partnership with Syrma Johari Medtech to expand its global production capacity, strengthen supply-chain resilience, and support an anticipated improvement of approximately 20 percentage points in gross margin ahead of its planned entry into the US market.

Market | 01/01/2026 | By News Bureau |  140

Silo Pharma Signs LOI with Allucent for Phase I Development of SPC-15

Silo Pharma has executed a Letter of Intent (LoI) with Allucent to support the phase I clinical development of SPC-15, with planned single-ascending dose and multiple-ascending dose studies representing a key clinical milestone for its intranasal treatment targeting PTSD and anxiety disorders.

Market | 31/12/2025 | By News Bureau |  143

Johnson & Johnson Acquires Halda Therapeutics to Strengthen Oncology Pipeline with RIPTAC Platform

Johnson & Johnson has completed the acquisition of Halda Therapeutics OpCo, Inc., a clinical-stage biotechnology company developing oral, targeted therapies for solid tumours using its proprietary Regulated Induced Proximity Targeting Chimera (RIPTAC) platform. The transaction was completed for USD 3.05 billion in cash.

Market | 31/12/2025 | By Darshana |  214